| [1] |
Berzigotti A, Reig M, Abraldes JG, et al. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis[J]. Hepatology, 2015, 61(2):526-536.
|
| [2] |
Huang JH, Gao F, Gu YK, et al. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization[J]. World J Gastroenterol, 2007, 13(48):6593-6397.
|
| [3] |
Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt （TIPS）in the management of portal hypertension: update 2009[J]. Hepatology, 2010, 51(1):306.
|
| [4] |
de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3):743-752.
|
| [5] |
Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma[J]. Gastroenterology, 2016, 150(4): 835-853.
|
| [6] |
Smith M, Ray CE. Splenic artery embolization as an adjunctive procedure for portal hypertensionJ]. Semin Intervent Radiol, 2012, 29(2): 135-139.
|
| [7] |
Gandini R, Merolla S, Chegai F, et al. Trans-splenic embolization plus partial splenic embolization for management of variceal bleeding due to left-sided portal hypertension[J]. Dig Dis Sci, 2018, 63(1): 264-267.
|
| [8] |
Duan X, Zhang K, Han X, et al. Comparison of percutaneous transhepatic variceal embolization（PTVE）followed by partial splenic embolization versus PTVE alone for the treatment of acute esophagogastric variceal massive hemorrhage[J]. J Vasc Interv Radiol, 2014, 25(12): 1858-1865.
|
| [9] |
Park JK, Saab S, Kee ST, et al. Balloon-occluded retrograde transvenous obliteration（BRTO）for treatment of gastric varices: Review and Meta-analysis[J]. Dig Dis Sci, 2015, 60(6): 1543-1553.
|
| [10] |
Saad WE, Wagner CC, Lippert A, et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration（BRTO）[J]. Am J Gastroenterol, 2013, 108(10): 1612-1619.
|